Lab-Grown Meat In America: What The Latest Sales Figures Show
Lab-grown meat sales in the U.S. are still tiny: the market has moved from "approved for sale" to only a handful of restaurant and limited retail test sales, so nationwide volume is best described as near zero at scale rather than a meaningful consumer category yet.
What the U.S. market looks like now
As of the latest public reporting, lab-grown meat is not widely sold in U.S. grocery stores or fast-food chains, and most sales have been limited to special events, chef partnerships, and short-run launches. The first federal approvals for sale arrived in 2023, but availability has remained highly restricted because production costs are still high and supply is limited.
The clearest real-world signal is that the category has only begun commercial rollout, with early products appearing in select restaurants and, more recently, isolated retail-style test sales in California. That means the U.S. is in a pre-mass-market phase, where unit sales exist but are too small to make a reliable national tally in the way analysts would track beef, chicken, or plant-based burgers.
How much is sold
There is no authoritative public number showing a large, steady U.S. sales base for lab-grown meat, and the evidence points to sales measured in very small batches rather than tons or even broad supermarket penetration. In practical terms, the amount sold in the U.S. right now is likely best understood as limited pilot volume, not a mainstream market.
Industry estimates about the broader U.S. "artificial meat" or "lab-grown meat" market vary widely, but those projections describe future revenue potential, not current consumer volume. For example, one market report pegs the U.S. lab-grown meat market at USD 0.25 billion in 2024 and projects growth to USD 1.8 billion by 2033, while another forecasts much higher figures for the wider artificial-meat category; those numbers should be treated cautiously because they are forecasts, not audited sales data.
Key milestones
The U.S. commercialization story started in 2023, when federal regulators cleared cultivated meat for sale and two companies-Upside Foods and Good Meat-became the first to complete the approval path. That approval mattered, but it did not instantly create a mass market, because restaurants and retailers still need economical production, distribution, and consumer adoption before sales can scale.
Early sales have appeared mainly in high-end dining, where novelty and premium pricing make small-volume deployment possible. In late 2025, the first grocery-store-style sale reported in the U.S. was described as a one-day event for cultivated pork meatballs in the Bay Area, underscoring how experimental the category still is.
Why sales stay small
The biggest constraint is cost. Cultivated meat requires controlled facilities, specialized growth media, and manufacturing systems that are still expensive compared with conventional meat, which keeps output low and retail pricing high.
- Production is still capacity-limited, so supply cannot yet support national distribution.
- Pricing remains premium, which narrows the customer base to chefs, early adopters, and media-driven trial purchases.
- Regulatory approval opened the door, but commercial logistics and consumer familiarity still take time.
- Most current sales are test batches, not recurring weekly volume across major chains.
Market snapshot
| Indicator | Current U.S. status | What it means |
|---|---|---|
| Regulatory status | Approved for sale since 2023 | Legal to market, but not widely distributed. |
| Sales channel | Mostly restaurants and limited tests | Volume remains small and localized. |
| Retail presence | Rare, event-based, or single-store trials | No broad supermarket rollout yet. |
| Public sales data | No comprehensive national total | Current sales are too small and fragmented to track cleanly. |
What analysts are watching
Analysts focus less on today's absolute sales count and more on whether cultivated meat can move from novelty to repeat purchase. The key question is whether production costs fall enough for regular retail pricing, because that will determine whether the category stays a niche curiosity or becomes a real protein segment.
"The market is no longer hypothetical, but it is still tiny in operational terms," is the clearest way to describe U.S. lab-grown meat today, based on the limited public evidence of actual sales and the still-small rollout footprint.
What this means for consumers
For shoppers, the practical answer is that lab-grown meat is sold in the U.S., but only in very limited quantities and in very limited places. If you are looking for it in a normal grocery trip, chances are you still will not find it on the shelf in most of the country.
For the industry, the current sales level is important because it marks the transition from regulatory theory to market reality. But until production expands and prices fall, the U.S. market will likely remain a story of pilot programs, chef menus, and occasional publicity-driven launches rather than large-scale supermarket demand.
How to read the numbers
- Separate sales from market forecasts, because many published figures are projections rather than current revenue.
- Look for actual distribution channels, because restaurant-only availability means low volume even when prices are high.
- Watch for repeat retail listings, because one-off launches do not equal durable demand.
- Track capacity announcements from producers, because output growth is the best proxy for future sales growth.
Bottom line for 2026
Lab-grown meat sales in the U.S. are real but still tiny, with the market best described as a handful of pilot and premium sales rather than a large consumer category. The clearest answer to "how much is sold" is that no meaningful national mass-market volume has emerged yet.
What are the most common questions about Lab Grown Meat In America What The Latest Sales Figures Show?
Is lab-grown meat sold in U.S. grocery stores?
Only in very limited, unusual cases so far, including event-style or one-day retail activity reported in California; it is not broadly available nationwide in ordinary supermarkets.
How much lab-grown meat is sold in the U.S. right now?
The amount sold appears to be very small, limited to pilot batches and niche restaurant or retail trials, with no public evidence of mass-market volume.
Why is sales volume so low?
High production costs, limited manufacturing capacity, and narrow distribution are keeping sales small even after federal approval opened the U.S. market.
Will sales grow quickly?
Sales could grow if production becomes cheaper and more scalable, but current public evidence suggests the category is still in its earliest commercial phase.